The newspaper Bergens Tidende (BT) published a major article yesterday about a recent study by NHH which has investigated the financial crisis and what we have learned from it. The study concludes that the high-tech start-up companies are among the first to perish in the midst of a global financial crisis. The small biotech company BerGenBio AS, a BTO startup company, is an example of the oposite. Before Christmas 2011, the company accomplished to raise substantial funding from investors, 52 mill NOK in equity capital.Read complete article here
Posts Tagged ‘børslokomotiver’
The biodream in Bergen – BerGenBio against the current in midst of financial crisis
Wednesday, January 18th, 2012BerGenBio AS raised NOK 52 MILL funding from investor group
Monday, January 9th, 2012The biotech company BerGenBio AS has now raised NOK 52 MILL funding from an investor group to finance a large clinical study with purpose to develop new cancer medicine. The BTO fund Norsk Innovasjonskapital II is one of the partners in this investor group, as well as the Bergen billionaire Trond Mohn. BTO has also contributed in the development and implementation of strategy, some legal aspects and accounting. BerGenBio is a spin-out company from BTO, and has experienced rapid growth the last year now counting 14 employees. Read Dagens Næringsliv article here
2009 et rekordår for forskningsbaserte ideer og oppfinnelser
Thursday, March 4th, 2010NTB har sjekket status ved BTO og alle de andre TTOene i Norge. TTO er kontorer som universitetene har etablert for å kommersialisere forskningsresultater. Resultatene viser at innovasjon fra forskningsmiljøene er i vekst – totalt sett ble 2009 et rekordår for forskningsbaserte idéer og oppfinnelser. Her ligger grunnlag for å skape nye børslokomotiver og mange arbeidsplasser.